HomePUR • WSE
add
Pure Biologics SA
Previous close
zł 4.46
Day range
zł 5.41 - zł 5.90
Year range
zł 2.22 - zł 13.02
Market cap
47.31M PLN
Avg Volume
30.41K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.26M | 27.38% |
Net income | -4.72M | -57.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.23M | -27.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 295.00K | 53.65% |
Total assets | 1.88M | -83.50% |
Total liabilities | 20.06M | 14.67% |
Total equity | -18.17M | — |
Shares outstanding | 4.08M | — |
Price to book | -1.00 | — |
Return on assets | -269.35% | — |
Return on capital | 468.41% | — |
Cash Flow
Net change in cash
| (PLN) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.72M | -57.72% |
Cash from operations | -184.00K | 97.56% |
Cash from investing | -16.00K | -100.70% |
Cash from financing | 267.00K | 72.26% |
Net change in cash | 67.00K | 101.31% |
Free cash flow | 2.71M | 166.59% |
About
Founded
2010
Website
Employees
6
